semaglutide ampule Flex-Dose 1 mL Injectable 2.5 mg/mL FDA Warns on Certain Forms

Infusion therapy is customized based on labs, symptoms, and goals

Andrew Trister, MD, PhD, Verily Chief Medical and Scientific Officer & Lifelong Health Study Principal Investigator Ultimately, Verilys Lifelong Health Study is poised to deliver RWD that is not simply generated, but continuously delivered, integrated, understood, and applied

Severe or persistent nausea is not always the medication

While retatrutide microdosing has not been formally studied for GI mitigation specifically, the principle is sound based on the dose-response data from clinical trials

Grimm A, Schmitt K, Eckert A

The slowed gastric emptying and altered gut motility caused by semaglutide may interact with the already dysregulated gut function characteristic of IBS